Prior GLP-1 receptor agonist use was associated with a significant decrease in mortality, infectious complications, and critical care utilisation among burn patients, independent of metabolic factors like BMI. These findings warrant prospective studies to optimize perioperative management strategies in this patient population.
Boukind et al. (Fri,) studied this question.